Prior to initiation of MR blockade, there was no difference in LBF or vascular conductance, between the individuals with type 2 diabetes and the control group, during infusion of incremental doses of ACh and SNP. This evidence concerns the gene NR3C2 and type 2 diabetes mellitus.